New York City based OneThree Biotech is raising $3,801,999.00 in New Equity Investment.
New York, NY – According to filings with the U.S. Securities and Exchange Commission, OneThree Biotech is raising $3,801,999.00 in new funding. Sources indicate as part of senior management President, Neel Madhukar played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About OneThree Biotech
At OneThree Biotech we’re combining advances in biology with new AI techniques to discover new cures for patients in need. By using AI to uncover insights from mountains of diverse data, we identify novel targets, compounds, and combinations that could lead to new treatments for patients in need.
To learn more about OneThree Biotech, visit http://onethree.bio/
Contact:
Neel Madhukar, President
865-224-6335
https://www.linkedin.com/in/neelmadhukar/
SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved